Research Studies

Geisinger is a health system that fosters learning. At ADMI, we want to learn more about your child’s special developmental needs. ADMI's innovative approach to patient care includes a robust research team investigating the causes of and treatment approaches to neurodevelopmental disorders. 

How to get started:

  1. Talk with your clinical care team to determine which studies are most appropriate for you and discuss exactly what is involved.
  2. Take the opportunity to discuss your questions with your clinical care team and decide if you want to participate.
  3. Enroll in a study and help us investigate the underlying causes of neurodevelopmental conditions as well as treatment approaches. 

You can participate in as many studies as you like and ask questions at any time. If for any reason you decide you no longer want to participate, you can stop at any time – this will not affect your child’s care at ADMI.

Making Advances Possible (MAP) Protocol

The MAP Protocol is focused on collecting detailed information about health and development to better understand neurodevelopmental conditions. Participants may conduct additional speech, behavioral, developmental, and/or neurological tests outside of what they might do in a normal clinic visit.

Geisinger MyCode® Community Health Initiative

This Geisinger-wide study involves collecting blood, saliva (spit), and health information from thousands of Geisinger patients for use in future research studies. By studying the genes and up-to-date medical information of a patient, researchers will be able to better understand, treat, or prevent different medical conditions.

17q12 Project

At ADMI, we are interested in better understanding the behavioral, developmental, and medical characteristics associated with extra or missing material in the 17q12 chromosomal region.

Sex Chromosome Disorders

As part of Geisinger’s MAP study, we are interested in understanding the extent to which family background influences learning and behavioral symptoms in individuals with Turner syndrome, Klinefelter syndrome, and Trisomy X.

GenomeConnect Survey Validation

At Geisinger’s Autism & Developmental Medicine Institute (ADMI) we want to help make sure we are gathering the best information we can from parents, because parents are the experts about their children’s health history. To that end, we are conducting research in which we are asking parents to help us improve health survey questionnaires used by GenomeConnect, a patient registry. By participating in our study, you can help us to understand the difference between what YOU know about your child’s health and what’s actually in our records. This project is related to GenomeConnect, the Clinical Genome Resource patient portal.

@geisingerADMI On Twitter

ADMI Events